🇺🇸 FDA
Patent

US 7371392

Cd40 ligand adjuvant for respiratory syncytial virus

granted A61KA61K2039/53A61K2039/55516

Quick answer

US patent 7371392 (Cd40 ligand adjuvant for respiratory syncytial virus) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/53, A61K2039/55516, A61K2039/57, A61K38/177